NCT00368056View on ClinicalTrials.gov

Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Primary Insomnia
Interventions
DRUG

Eszopiclone

eszopiclone 3 mg

DRUG

Placebo

Placebo tablet

Trial Locations (1)

Unknown

HPRU Medical Research Centre, University of Surrey, Guildford

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00368056 - Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability | Biotech Hunter | Biotech Hunter